Chugai Pharmaceutical Co., Ltd. (TYO:4519)
6,885.00
+38.00 (0.55%)
Aug 19, 2026, 3:30 PM JST
Chugai Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Hold Maintains ¥8,800 → ¥7,500 | Hold | Maintains | ¥8,800 → ¥7,500 | +8.93% | Aug 14, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Downgrades ¥9,800 → ¥7,200 | Hold | Downgrades | ¥9,800 → ¥7,200 | +4.58% | Aug 6, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains ¥13,500 → ¥13,300 | Buy | Maintains | ¥13,500 → ¥13,300 | +93.17% | Jul 28, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains ¥9,800 | Buy | Maintains | ¥9,800 | +42.34% | Jul 27, 2026 |
| Jefferies | Jefferies | Hold Reiterates ¥8,500 → ¥8,000 | Hold | Reiterates | ¥8,500 → ¥8,000 | +16.19% | Jul 27, 2026 |
| Bernstein | Bernstein | Buy Maintains ¥9,800 | Buy | Maintains | ¥9,800 | +42.34% | Jul 7, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains ¥10,000 | Buy | Maintains | ¥10,000 | +45.24% | Jul 1, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Upgrades ¥8,950 | Buy | Upgrades | ¥8,950 | +29.99% | Jun 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.